The TIMI risk score for unstable angina and NSTEMI is a seven-point clinical tool used to estimate the short-term risk of death, myocardial infarction, or urgent revascularization in patients with suspected or confirmed non-ST-elevation acute coronary syndrome. Each criterion is worth one point, producing a total score from 0 to 7. A higher score indicates greater risk, but the result must be interpreted alongside symptoms, serial electrocardiograms, high-sensitivity troponin testing, bleeding risk, comorbidities, and clinical judgment.
What Is the TIMI Risk Score?
The TIMI risk score was developed from patients enrolled in the TIMI 11B trial and validated in the ESSENCE trial. It was designed as a simple bedside method for risk stratification in unstable angina and non-ST-elevation myocardial infarction, collectively called non-ST-elevation acute coronary syndrome.
The original score predicts a composite outcome within 14 days:
- All-cause death
- New or recurrent myocardial infarction
- Severe recurrent ischemia requiring urgent revascularization
The score is primarily a prognostic tool. It does not diagnose acute coronary syndrome and should not be used to rule out myocardial infarction.
TIMI Risk Score Criteria for Unstable Angina and NSTEMI
Assign one point for each criterion present at the time of assessment.
| Criterion | Points |
|---|---|
| Age 65 years or older | 1 |
| At least three traditional coronary artery disease risk factors | 1 |
| Known coronary artery stenosis of 50% or greater | 1 |
| ST-segment deviation on the presenting electrocardiogram | 1 |
| At least two anginal episodes in the previous 24 hours | 1 |
| Aspirin use during the previous seven days | 1 |
| Elevated cardiac biomarkers | 1 |
Total score: 0 to 7 points.
What Counts as a Coronary Artery Disease Risk Factor?
In the original TIMI model, commonly considered risk factors included hypertension, diabetes mellitus, hypercholesterolemia, current smoking, and a family history of premature coronary artery disease. Local protocols may specify how these variables are defined.
What Is Meant by Elevated Cardiac Biomarkers?
The original study used the cardiac-marker assays available at the time. Contemporary practice relies mainly on cardiac troponin, particularly high-sensitivity troponin. Troponin results must be interpreted according to the assay-specific 99th-percentile reference limit, the pattern of change on serial testing, symptom timing, renal function, and the wider clinical context.
How to Calculate the TIMI Risk Score
- Confirm that the clinical scenario is compatible with unstable angina or NSTEMI.
- Review the patient’s age, cardiovascular risk factors, and history of documented coronary stenosis.
- Assess the presenting electrocardiogram for ST-segment deviation.
- Determine whether at least two anginal episodes occurred in the preceding 24 hours.
- Ask about aspirin use during the previous seven days.
- Review cardiac biomarker results.
- Add one point for every criterion present.
Worked Example
A 68-year-old patient presents with recurrent chest discomfort. The patient has hypertension, diabetes, and hypercholesterolemia; has known 60% coronary stenosis; reports three episodes of angina during the previous day; and has an elevated troponin. There is no ST-segment deviation, and aspirin was not used during the previous week.
- Age 65 or older: 1 point
- At least three coronary risk factors: 1 point
- Known stenosis of 50% or greater: 1 point
- At least two anginal episodes in 24 hours: 1 point
- Elevated cardiac biomarker: 1 point
Total TIMI score: 5. This indicates a comparatively high short-term event risk within the population for which the score was developed. It does not, by itself, determine the timing of angiography or the exact treatment plan.
TIMI Risk Score Interpretation
In the original validation cohort, the 14-day event rate increased progressively as the score rose.
| TIMI score | Original 14-day composite event rate |
|---|---|
| 0-1 | 4.7% |
| 2 | 8.3% |
| 3 | 13.2% |
| 4 | 19.9% |
| 5 | 26.2% |
| 6-7 | 40.9% |
These percentages come from the original trial population and should not be treated as exact individualized probabilities in modern practice. Changes in troponin assays, preventive therapies, invasive strategies, and patient populations may alter absolute risk.
How the TIMI Score Is Used Clinically
The TIMI risk score can support early communication and structured risk assessment in patients with non-ST-elevation acute coronary syndrome. It may help clinicians:
- Recognize patients with a greater likelihood of short-term ischemic complications
- Communicate prognosis consistently within the clinical team
- Complement electrocardiographic, biomarker, imaging, and clinical findings
- Support decisions about monitoring intensity and specialist evaluation
- Stratify participants in research or quality-improvement work
Current acute coronary syndrome management is not based on the TIMI score alone. Contemporary guidelines emphasize an integrated assessment that includes hemodynamic stability, ongoing or recurrent ischemia, arrhythmias, heart failure, serial high-sensitivity troponin values, electrocardiographic changes, renal function, bleeding risk, and coronary anatomy when available.
TIMI Score Versus GRACE Score
| Feature | TIMI score | GRACE score |
|---|---|---|
| Complexity | Seven binary variables; quick to calculate | Uses multiple weighted continuous and categorical variables |
| Typical purpose | Short-term ischemic risk in UA/NSTEMI | In-hospital and post-discharge mortality risk across acute coronary syndromes |
| Discrimination | Useful but relatively simple | Generally provides more detailed prognostic discrimination |
| Bedside use | Easy without a calculator | Usually calculated electronically |
The TIMI score is convenient and memorable, while the GRACE score is often preferred when more precise mortality risk estimation is required. The choice depends on the clinical question, available data, and local protocol.
Important Limitations
It Does Not Diagnose NSTEMI
A low TIMI score cannot exclude myocardial infarction or another dangerous cause of chest pain. Diagnosis requires clinical assessment, electrocardiography, and appropriately timed troponin testing.
Binary Variables Lose Clinical Detail
The score gives the same single point to all qualifying abnormalities. It does not distinguish, for example, between minor and extensive ST-segment changes, modest and marked troponin elevation, or age 65 and advanced age.
The Original Outcome Is a Composite
The predicted endpoint combines death, myocardial infarction, and urgent revascularization. These outcomes differ in clinical severity, so the score should not be interpreted as a pure mortality calculator.
Modern Practice Has Changed
The TIMI score predates widespread high-sensitivity troponin testing, contemporary antiplatelet strategies, current stent technology, and many present-day invasive pathways. Absolute event rates from the original publication may therefore differ from those seen in current populations.
It Omits Several Important Risk Features
The score does not directly include blood pressure, heart rate, cardiac arrest, heart failure severity, renal function, anemia, frailty, active bleeding, or overall bleeding risk. These factors can substantially alter management.
It Is Not Intended for STEMI
The UA/NSTEMI TIMI score should not be substituted for immediate STEMI pathways. Patients with persistent ST-segment elevation or another indication for emergency reperfusion require urgent management according to established protocols.
When Urgent Assessment Is Needed
Chest pressure, tightness, or pain accompanied by sweating, shortness of breath, fainting, severe weakness, new confusion, persistent symptoms, or discomfort spreading to the arm, jaw, back, or upper abdomen may represent an acute coronary syndrome. Emergency medical assessment is appropriate, particularly when symptoms are ongoing, recurrent, or associated with hemodynamic instability.
Key Takeaways
- The TIMI risk score uses seven one-point variables and ranges from 0 to 7.
- It estimates 14-day risk of death, myocardial infarction, or urgent revascularization in UA/NSTEMI populations.
- A higher score indicates increasing short-term ischemic risk.
- The score supports prognosis but does not diagnose or exclude NSTEMI.
- Clinical decisions should integrate symptoms, serial ECGs, high-sensitivity troponin, comorbidities, bleeding risk, and guideline-based assessment.
Frequently Asked Questions
What is a high TIMI risk score?
Risk rises progressively with each point. Scores of 5 to 7 represented the highest-risk groups in the original study, but treatment should not be determined by a numerical cutoff alone.
Can a TIMI score of 0 rule out a heart attack?
No. A score of 0 does not mean zero risk and cannot rule out myocardial infarction. Serial troponin testing, electrocardiograms, symptoms, and clinical assessment remain necessary.
Why does recent aspirin use add a point?
In the original model, recent aspirin use identified patients who developed unstable symptoms despite antiplatelet exposure, which was associated with greater risk. It should not be interpreted as evidence that aspirin itself causes the increased risk.
Is the TIMI score better than the GRACE score?
Neither score is best for every purpose. TIMI is simpler and faster, while GRACE generally offers more detailed risk estimation and is commonly used for mortality-related stratification.
Can patients calculate the TIMI score themselves?
Although the variables appear simple, several require clinical interpretation, including ECG changes, cardiac biomarker elevation, and confirmation of coronary stenosis. The score is best calculated and interpreted by a qualified healthcare professional.
Medical disclaimer: This article is for education and professional reference only. It does not diagnose, exclude, or treat acute coronary syndrome. Anyone with possible heart-attack symptoms should seek urgent medical assessment rather than relying on an online score.
Key takeaways
- The TIMI score assigns one point for each of seven clinical variables.
- It estimates 14-day risk of death, myocardial infarction, or urgent revascularization in UA/NSTEMI.
- Higher scores correspond to progressively greater short-term event risk.
- A low score cannot rule out NSTEMI or another serious cause of chest pain.
- The score should complement, not replace, contemporary clinical assessment and guideline-directed care.
Frequently asked questions
What is a high TIMI risk score?
Can a TIMI score of 0 rule out a heart attack?
Why does recent aspirin use add one point?
Is TIMI better than the GRACE score?
Does the TIMI score determine treatment?
References
- Antman EM, Cohen M, Bernink PJLM, et al. The TIMI Risk Score for Unstable Angina/Non-ST Elevation MI: A Method for Prognostication and Therapeutic Decision Making. JAMA. 2000;284(7):835-842. https://jamanetwork.com/journals/jama/fullarticle/192996
- Rao SV, O'Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation. 2025. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309
- Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. European Heart Journal. 2023;44(38):3720-3826. https://doi.org/10.1093/eurheartj/ehad191